278
Participants
Start Date
January 31, 2006
Primary Completion Date
September 30, 2009
Study Completion Date
December 31, 2009
Degarelix
"Participants who completed the main study initially continued with the same dose in the FE200486 CS15A extension study. A protocol amendment changed the dosage to 360 mg (60 mg/mL) or 480 mg (60 mg/mL).~Drug supplied as a powder to be dissolved in the solvent for solution for injection. Degarelix given by subcutaneous injection every 3 months until the end of the study."
Degarelix
"Participants who completed the main study initially continued with the same dose in the FE200486 CS15A extension study. A protocol amendment changed the dosage to 360 mg (60 mg/mL) or 480 mg (60 mg/mL).~Drug supplied as a powder to be dissolved in the solvent for solution for injection. Degarelix given by subcutaneous injection every 3 months until the end of the study."
Degarelix
"Participants who completed the main study initially continued with the same dose in the FE200486 CS15A extension study. A protocol amendment changed the dosage to 360 mg (60 mg/mL) or 480 mg (60 mg/mL).~Drug supplied as a powder to be dissolved in the solvent for solution for injection. Degarelix given by subcutaneous injection every 3 months until the end of the study."
UZ Gasthuisberg Leuven, Leuven
Helsinki University Hospital, Maria Hospital, Building 11, Helsinki
Central Hospital, North Karelian, Joensuu
Oulu University Hospital, Oulu
Tampere University Hospital, Tampere
Fédération d'Urologie et Néphrologie, BP69 Hôpital Pasteur, Nice
Gemeinschaftspraxis Dres Effert und Benedic, Aachen
Clinical Center Novi Sad, Clinic of Urology, Novi Sad
Academic Medical Center, Urology, Amsterdam
St. Elisabeth Hospital, Tilburg
"Centrul Medical Privat Prof. Dr. Ioiart Ioan", Arad
"Clinical Hospital Prof. Dr. Theodor Burghele, Urology Department", Bucharest
University CF Hospital No. 2, Bucharest
Andros Clinic, Saint Petersburg
City Hospital #15, Saint Petersburg
City Hospital #26, Saint Petersburg
Pavlov State Medical University, Outpatient Diagnostic Center affiliated with the Urology Department, Saint Petersburg
Pavlov State Medical University, Urology Department, Saint Petersburg
Clinical Center of Serbia, Institute of Urology and Nephrology, Belgrade
Mount Vernon Cancer Centre, Marie Cuire Research Wing, Northwood
Castle Hill Hospital, Hull
Ward 13, NHS Forth Valley Acute Operating Division, Falkirk and District Royal Infirmary, Majors Loans, Falkirk
Level 7, Urology Research Unit, Derriford Hospital, Plymouth
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY